Cargando…

Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients

Effective antiretroviral (ARV) therapy depends on adequate drug exposure, yet methods to assess ARV exposure are limited. Concentrations of ARV in hair are the product of steady-state pharmacokinetics factors and longitudinal adherence. We investigated nevirapine (NVP) concentrations in hair as a pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baxi, Sanjiv M., Greenblatt, Ruth M., Bacchetti, Peter, Jin, Chengshi, French, Audrey L., Keller, Marla J., Augenbraun, Michael H., Gange, Stephen J., Liu, Chenglong, Mack, Wendy J., Gandhi, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460031/ https://www.ncbi.nlm.nih.gov/pubmed/26053176 http://dx.doi.org/10.1371/journal.pone.0129100

Ejemplares similares

Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)
por: Liu, Albert Y., et al.
Publicado: (2014)

The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2014)

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship
por: Bhatt, Nilesh B., et al.
Publicado: (2015)

Nevirapine Plasma Concentrations Are Associated with Virologic Response and Hepatotoxicity in Chinese Patients with HIV Infection
por: Wang, Jia, et al.
Publicado: (2011)

Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death
por: Heck, Carley J. S., et al.
Publicado: (2020)

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial
por: Baxi, Sanjiv M., et al.
Publicado: (2018)

Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures
por: Baxi, Sanjiv M., et al.
Publicado: (2015)

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort
por: Rokx, Casper, et al.
Publicado: (2014)

48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)
por: Arastéh, K, et al.
Publicado: (2010)

Plasma nevirapine concentrations predict virological and adherence failure in Kenyan HIV-1 infected patients with extensive antiretroviral treatment exposure
por: Kimulwo, Maureen J., et al.
Publicado: (2017)

LC-MS/MS Quantification of Nevirapine and Its Metabolites in Hair for Assessing Long-Term Adherence
por: Yang, Haoran, et al.
Publicado: (2020)

Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan
por: Lee, Chun-Yuan, et al.
Publicado: (2017)

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens
por: Bommenel, T, et al.
Publicado: (2010)

Preparation and Characterisation of Nevirapine Oral Nanosuspensions
por: Raju, Anju, et al.
Publicado: (2014)

Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?
por: Sarfo, Fred Stephen, et al.
Publicado: (2014)

The impact of nevirapine- versus protease inhibitor-based regimens on virological markers of HIV-1 persistence during seemingly suppressive ART
por: Kiselinova, Maja, et al.
Publicado: (2014)

Solid-State Characterization of Nevirapine
por: Sarkar, Mahua, et al.
Publicado: (2008)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Virological failure of staggered and simultaneous treatment interruption in HIV patients who began Efavirenz-based regimens after allergic reactions to nevirapine
por: Siripassorn, Krittaecho, et al.
Publicado: (2013)

Association of Self-Reported Adherence and Antiretroviral Drug Concentrations in Hair Among Youth with Virologic Failure in Tanzania
por: Tabb, Zachary, et al.
Publicado: (2017)

Nevirapine plasma concentration is associated with virologic failure and the emergence of drug-resistant mutations among HIV patients in Kenya: A cross sectional study
por: Omondi, Evans Okumu, et al.
Publicado: (2022)

Low-temperature study of a new nevirapine pseudopolymorph
por: da Silva, C. C. P., et al.
Publicado: (2007)

Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study
por: Lee, Yi-Chieh, et al.
Publicado: (2015)

A genomic variant of ALPK2 is associated with increased liver fibrosis risk in HIV/HCV coinfected women
por: McIntosh, Alec T., et al.
Publicado: (2021)

Development of a liposomal nanodelivery system for nevirapine
por: Ramana, Lakshmi N, et al.
Publicado: (2010)

DRESS Syndrome due to Nevirapine Treated with Methylprednisolone
por: Pott Junior, Henrique, et al.
Publicado: (2013)

Antioxidant modulation of nevirapine induced hepatotoxicity in rats
por: Awodele, Olufunsho, et al.
Publicado: (2015)

Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study
por: Desai, Seema N., et al.
Publicado: (2016)

Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis
por: Gerona, Roy, et al.
Publicado: (2016)

Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants
por: Moorthy, Anitha, et al.
Publicado: (2009)

Adverse Events in a Cohort of HIV Infected Pregnant and Non-Pregnant Women Treated with Nevirapine versus Non-Nevirapine Antiretroviral Medication
por: Aaron, Erika, et al.
Publicado: (2010)

Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis
por: Permar, Sallie R, et al.
Publicado: (2013)

Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study
por: Lau, Bryan, et al.
Publicado: (2010)

Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial
por: Petchkum, Porkaew, et al.
Publicado: (2019)

Nevirapine induced exfoliative dermatitis in an HIV-infected patient
por: Bhandarkar, Anoosha P., et al.
Publicado: (2011)

Floating Drug Delivery of Nevirapine as a Gastroretentive System
por: Vedha, Hari BN, et al.
Publicado: (2010)

Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS)
por: Gill, Shaman, et al.
Publicado: (2013)

Investigating the continuous synthesis of a nicotinonitrile precursor to nevirapine
por: Longstreet, Ashley R, et al.
Publicado: (2013)

Clinical and genetic determinants of nevirapine plasma trough concentration
por: Giacomelli, Andrea, et al.
Publicado: (2018)

Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals
por: Panzade, Prabhakar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dv8q80umn8nt5m0e70de25jrt1